mous
hepat
viru
repres
member
genu
betacoronaviru
within
subfamili
coronavirina
infect
liver
brain
respiratori
tract
differ
inocul
rout
provid
anim
model
enceph
hepat
pneumonia
explor
viral
life
machineri
virushost
interact
viral
replic
nonstructur
protein
also
term
main
proteas
pro
play
domin
role
process
coronavirusencod
polyprotein
thu
recogn
ideal
target
anticoronaviru
agent
howev
structur
pro
report
molecular
explor
catalysi
mechan
remain
hinder
solv
crystal
structur
pro
complex
michael
acceptorbas
inhibitor
structur
analysi
reveal
cb
vinyl
group
coval
bound
catalyt
dyad
pro
irrevers
inactiv
cystein
proteas
activ
lactam
ring
side
chain
isobutyl
group
side
chain
mimic
conserv
residu
posit
substrat
fit
well
pocket
compar
studi
pro
coronavirus
observ
substraterecognit
pocket
enzym
inhibitori
mechan
highli
conserv
altogeth
studi
provid
structur
featur
pro
indic
michael
acceptor
inhibitor
ideal
scaffold
antivir
drug
coronavirus
cov
larg
group
envelop
positivestrand
rna
virus
infect
wide
rang
speci
includ
anim
human
caus
respiratori
hepat
gastrointestin
ill
cov
divid
four
main
genera
alphacoronaviru
includ
anim
pathogen
porcin
epidem
diarrhea
viru
pedv
felin
infecti
periton
viru
fipv
well
human
cov
human
cov
betacoronaviru
also
includ
pathogen
veterinari
relev
bovin
coronaviru
bcov
equin
coronaviru
ecov
mous
hepat
viru
mhv
well
human
cov
human
cov
sar
coronaviru
sarscov
mer
coronaviru
merscov
gammacoronaviru
thu
far
includ
avian
coronavirus
infecti
bronchiti
viru
ibv
deltacoronaviru
newli
discov
genu
includ
bulbul
coronaviru
betacoronaviru
divid
subgroup
contain
differ
hcov
betacoronaviru
contain
pathogen
caus
sever
respiratori
syndrom
human
anim
also
carri
high
risk
interspeci
transmiss
zoonot
reservoir
human
featur
make
research
hotspot
mhv
belong
betacoronaviru
subgroup
natur
pathogen
specif
infect
mice
differ
inocul
rout
liver
gastrointestin
tract
central
nervou
system
cn
mhv
caus
wide
rang
diseas
mhv
infect
mous
consid
one
best
anim
model
studi
virushost
interact
commonli
use
laboratori
strain
thu
provid
anim
model
hepat
autoimmun
hepatitislik
diseas
enceph
demyelin
diseas
genom
kb
length
encod
two
larg
polyprotein
sever
structur
protein
includ
nucleocapsid
protein
n
envelop
protein
e
spike
protein
matrix
protein
addit
varieti
accessori
protein
two
polyprotein
need
cleav
nonstructur
protein
nsp
assembl
replicationtranscript
complex
requir
genom
replic
also
term
proteas
main
proteas
pro
mediat
proteolysi
distinct
cleavag
site
essenti
viru
replic
due
high
conserv
low
mutat
recombin
rate
pro
thought
potenti
target
widespectrum
inhibitor
design
owe
domin
vital
role
viru
fit
viral
growth
numer
studi
pro
report
one
hand
fundament
molecular
catalyt
mechan
unravel
studi
crystal
structur
pro
complex
peptid
substrat
analog
pro
observ
exhibit
conserv
threedomain
structur
domain
domain
ii
form
chymotrypsinlik
fold
proteolysi
domain
iii
mainli
particip
format
homodim
catalyt
site
catalyt
dyad
potenti
substratebind
pocket
discov
hand
regul
pro
activ
investig
gain
deeper
understand
cleavag
mechan
first
found
proteas
activ
pro
could
relat
homodimer
way
longdist
commun
identifi
temperaturesensit
defect
mutant
could
readili
recov
secondsit
mutat
n
interestingli
residu
distant
catalyt
site
substratebind
pocket
dimer
interfac
due
lack
structur
pro
underli
mechan
regul
proteas
activ
replic
remain
larg
unclarifi
studi
introduc
mutat
improv
biophys
biochem
properti
pro
thu
obtain
crystal
structur
pro
complex
synthet
peptidomimet
inhibitor
detail
structur
studi
lead
us
better
understand
alloster
mechan
provid
structur
basi
ration
drug
design
code
sequenc
main
proteas
synthet
clone
selfconstruct
vector
use
bamhi
xhoi
restrict
site
mutat
introduc
plasmid
sitedirect
mutagenesi
use
easi
sitedirect
mutagenesi
kit
transgen
beij
china
basi
construct
delet
introduc
overlap
extens
pcr
recombin
plasmid
verifi
sequenc
plasmid
transform
e
coli
strain
strain
grown
lb
broth
contain
mgml
kanamycin
c
od
protein
express
induc
ad
mm
iptg
cultur
c
h
cell
harvest
follow
sonic
lysi
cell
lysat
prepar
use
centrifug
g
min
c
ninta
affin
resin
ge
healthcar
usa
use
captur
sumotag
target
protein
lysat
sumo
tag
remov
oncolumn
cleavag
use
sumo
proteas
ulp
c
h
result
protein
interest
appli
hitrap
q
column
ge
healthcar
usa
linear
gradient
mm
mm
nacl
mm
trishcl
ph
glycerol
target
protein
collect
purifi
use
superdex
column
ge
healthcar
usa
buffer
consist
mm
hepe
ph
mm
nacl
purifi
pro
protein
supplement
dmso
concentr
mgml
use
thermo
icon
concentr
inhibitor
dissolv
dmso
final
concentr
mm
stock
ad
purifi
protein
molar
ratio
incub
c
h
protein
complex
centrifug
g
min
concentr
mgml
buffer
contain
mm
hepe
ph
mm
nacl
mm
dtt
use
microbatchunderoil
method
best
crystal
obtain
two
day
condit
contain
sodium
acet
trihydr
ph
wv
polyethylen
glycol
crystal
cryoprotect
solut
contain
sodium
acet
trihydr
ph
wv
polyethylen
glycol
glycerol
mount
nylon
loop
flash
cool
nitrogen
stream
k
xray
diffract
data
set
collect
use
ccd
detector
beamlin
shanghai
synchrotron
radiat
facil
ssrf
intens
data
index
integr
scale
packag
structur
pro
determin
molecular
replac
mr
use
model
pro
pdb
id
programm
phaser
refin
perform
phenixrefin
cycl
manual
rebuild
coot
structur
refin
resolut
collect
refin
statist
shown
tabl
access
code
protein
data
bank
due
delet
number
amino
acid
greater
pdb
file
need
correct
ad
enzymat
assay
perform
continu
kinet
assay
mm
trishcl
ph
mm
edta
use
fluorogen
substrat
mcaavlqsgfrli
dnp
puriti
gl
biochem
shanghai
ltd
shanghai
china
previous
report
reaction
initi
ad
ml
substrat
final
concentr
span
mm
ml
proteas
solut
final
proteas
concentr
mm
inhibit
assay
substrat
mix
final
substrat
concentr
mm
final
concentr
span
nm
fluoresc
intens
monitor
speed
measur
c
use
fluoroskan
ascent
instrument
thermo
scientif
usa
excit
emiss
wavelength
nm
nm
respect
kinet
paramet
includ
k
k
cat
pro
pro
k
k
inhibitor
determin
method
describ
detail
previou
work
graphpad
prism
softwar
one
asymmetr
unit
occupi
three
protein
molecul
denot
b
c
one
molecul
per
protom
fig
among
protom
b
protom
c
form
homodim
typic
cov
pro
protom
dimer
counterpart
adjac
symmetryrel
unit
fig
protom
display
threedomain
iii
architectur
domain
residu
domain
ii
residu
togeth
constitut
chymotrypsinlik
fold
domain
iii
residu
exhibit
five
antiparallel
ahelic
arrang
larg
globular
cluster
substratebind
site
situat
cleft
domain
domain
ii
catalyt
dyad
compos
center
substratebind
site
whole
pocket
compris
two
featur
deepli
buri
site
sever
solventexpos
site
accommod
differ
side
chain
substrat
domain
iii
locat
right
domain
ii
connect
loop
contribut
mainli
homodim
format
fig
furthermor
locat
loop
region
domain
iii
close
residu
dimer
interfac
interestingli
temperaturesensit
suppressor
also
situat
nearbi
numer
structur
studi
cov
pro
welldesign
michael
acceptor
inhibitor
frequent
use
captur
transit
state
proteolysi
process
detail
mechan
shown
equat
first
inhibitor
enzym
form
revers
complex
ei
equilibriumbind
constant
k
cystein
situat
enzym
activ
site
undergo
nucleophil
attack
reactiv
atom
inhibitor
lead
format
stabl
coval
bond
ei
determin
k
k
reveal
potent
inhibit
pro
tabl
inhibitorbound
pro
structur
observ
clear
continu
electron
densiti
cb
vinyl
group
sg
atom
confirm
format
coval
bond
intermedi
state
stabil
catalyt
dyad
oxyanion
loop
backbon
amid
form
oxyanion
hole
fig
conform
oxyanion
loop
tighten
intern
hydrogen
bond
side
chain
oxygen
backbon
nitrogen
correct
posit
oxyanion
loop
maintain
follow
interact
hydrogen
bond
backbon
oxygen
atom
amid
group
nitrogen
atom
side
chain
ii
hydrogen
bond
oxygen
atom
side
chain
imidazol
ring
iii
hydrophob
stack
imidazol
ring
benzen
ring
therefor
side
chain
help
strengthen
hydrophob
stack
form
hydrogen
bond
residu
thu
maintain
oxyanion
loop
proper
posit
sinc
lactam
ring
side
chain
play
crucial
role
catalyt
process
glutamin
seem
competit
residu
posit
pro
substrat
accord
analysi
genom
sequenc
found
pro
cleavag
site
possess
glutamin
posit
strong
prefer
glutamin
also
common
featur
cov
pro
structur
pocket
constitut
suitabl
accommod
lactam
ring
fig
protrud
lactam
ring
form
hydrogen
bond
aforement
imidazol
ring
backbon
oxygen
atom
ii
side
chain
distanc
compar
cov
pocket
volum
similar
smaller
ibv
sarscov
size
reduct
pocket
mainli
attribut
upward
bend
loop
smaller
pocket
could
better
accommod
smaller
imidazol
ring
histidin
cleavag
site
howev
smaller
pocket
necessari
substitut
observ
posit
base
comparison
proteas
recognit
site
genom
perform
previous
found
pro
gener
prefer
hydrophob
residu
posit
also
report
nearli
cov
although
leucin
methionin
abund
mani
altern
residu
valin
isoleucin
phenylalanin
prolin
also
observ
might
impli
less
stringenc
specif
inhibitor
bear
aliphat
isobutyl
group
site
mimic
leucin
side
chain
complex
structur
larg
hydrophob
side
chain
deepli
protrud
buri
pocket
via
hydrophob
interact
side
chain
well
accommod
onto
van
der
waal
surfac
pocket
fig
residu
constitut
complet
pocket
also
includ
form
groupspecif
lid
arrang
short
helic
region
worth
mention
delet
lead
reduct
lid
volum
make
pocket
partial
expos
solvent
combin
enzymolog
data
measur
found
delet
lower
k
k
cat
accept
degre
tabl
except
strong
prefer
residu
residu
cleavag
site
exhibit
specif
particular
side
chain
among
cov
pro
consist
observ
isopropyl
group
side
chain
solvent
expos
three
protom
pro
backbon
carbonyl
oxygen
nh
form
hydrogen
bond
nh
backbon
carbonyl
oxygen
respect
help
fix
inhibitor
pro
locat
fig
side
chain
posit
methyl
group
suitabl
accommod
rel
shallow
pocket
small
insert
side
chain
form
hydrophob
interact
addit
backbon
nh
donat
weak
hydrogen
bond
carbonyl
oxygen
isoxazol
posit
also
partial
solvent
expos
form
van
der
waal
interact
backbon
residu
fig
summari
inhibitor
interact
pro
similar
pattern
cov
pro
pathogen
model
commonli
use
explor
virushost
interact
mani
cov
compar
pro
structur
variou
cov
sarscov
merscov
pedv
ibv
fig
cov
exhibit
similar
shape
pro
rmsd
distinct
cov
pedv
rmsd
ibv
rmsd
comparison
show
domain
domain
ii
overlap
well
rmsd
domain
iii
link
loop
exhibit
slight
shift
ca
domain
iii
ibv
differ
rmsd
consid
similar
topolog
structur
domain
ieiii
differ
pedv
pro
like
caus
reorient
connect
loop
crystal
pack
moreov
groupspecif
lid
also
display
divers
conform
howev
structur
divers
report
caus
groupspecif
substrat
prefer
overal
structur
align
demonstr
signific
homolog
among
cov
perform
closer
inspect
substratebind
pocket
bound
inhibitor
catalyt
dyad
maintain
oxyanion
loop
proper
rel
posit
complet
conserv
bind
pocket
compris
residu
mostli
conserv
especi
pocket
residu
directli
interact
side
chain
form
fundament
part
pocket
complet
ident
pocket
pocket
pocket
residu
construct
outer
wall
interact
backbon
bear
solventexpos
side
chain
exhibit
substitut
type
amino
acid
fig
taken
togeth
result
show
michael
acceptor
suicid
inhibitor
interact
pro
manner
conserv
among
variou
cov
last
two
decad
global
epidem
sarscov
merscov
cov
arous
widespread
concern
call
effect
therapeut
prevent
strategi
combin
anim
infect
model
would
facilit
studi
cov
pathogenesi
antivir
drug
develop
studi
first
obtain
crystal
high
qualiti
pro
prototyp
strain
anim
infect
model
determin
structur
high
resolut
introduc
seri
mutat
engin
biophys
chemic
properti
structur
pattern
interact
pro
gener
similar
cov
pro
catalyt
dyad
form
irrevers
coval
bond
stabil
loop
form
oxyanion
hole
meanwhil
lactam
ring
side
chain
isobutyl
group
side
chain
protrud
pocket
well
respect
pocket
character
prefer
cleavag
recognit
site
glutamin
leucinemethionin
residu
constitut
whole
bind
pocket
larg
conserv
altogeth
find
help
develop
potent
inhibitor
carri
michael
acceptor
warhead
drug
exist
possibl
emerg
human
cov
